Home Newsletters Pancreatic Cell News Pancreatic Cancer Prognosis Is Predicted by an ATAC-Array Technology for Assessing Chromatin...

Pancreatic Cancer Prognosis Is Predicted by an ATAC-Array Technology for Assessing Chromatin Accessibility

0
By ATAC-seq analyses of EpCAM+ pancreatic ductal adenocarcinoma malignant epithelial cells sorted from 54 freshly resected human tumors, we show here the discovery of a signature of 1092 chromatin loci displaying differential accessibility between patients with disease free survival (DFS) 1 year.
[Nature Communications]
7753456 {7753456:GPR5C4IJ} apa 50 1 162574 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b82ab7535f385ee363e2283d4fa63fcf%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22GPR5C4IJ%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dhara%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDhara%2C%20S.%2C%20Chhangawala%2C%20S.%2C%20Chintalapudi%2C%20H.%2C%20Askan%2C%20G.%2C%20Aveson%2C%20V.%2C%20Massa%2C%20A.%20L.%2C%20Zhang%2C%20L.%2C%20Torres%2C%20D.%2C%20Makohon-Moore%2C%20A.%20P.%2C%20Lecomte%2C%20N.%2C%20Melchor%2C%20J.%20P.%2C%20Bermeo%2C%20J.%2C%20Cardenas%2C%20A.%2C%20Sinha%2C%20S.%2C%20Glassman%2C%20D.%2C%20Nicolle%2C%20R.%2C%20Moffitt%2C%20R.%2C%20Yu%2C%20K.%20H.%2C%20Leppanen%2C%20S.%2C%20%26%23x2026%3B%20Leach%2C%20S.%20D.%20%282021%29.%20Pancreatic%20cancer%20prognosis%20is%20predicted%20by%20an%20ATAC-array%20technology%20for%20assessing%20chromatin%20accessibility.%20%3Ci%3ENature%20Communications%3C%5C%2Fi%3E%2C%20%3Ci%3E12%3C%5C%2Fi%3E%281%29%2C%203044.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-021-23237-2%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-021-23237-2%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DGPR5C4IJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pancreatic%20cancer%20prognosis%20is%20predicted%20by%20an%20ATAC-array%20technology%20for%20assessing%20chromatin%20accessibility%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Dhara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Chhangawala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Chintalapudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Askan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Aveson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20L.%22%2C%22lastName%22%3A%22Massa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20P.%22%2C%22lastName%22%3A%22Makohon-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Lecomte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20P.%22%2C%22lastName%22%3A%22Melchor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Bermeo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Cardenas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Glassman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Nicolle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Moffitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Leppanen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Laderman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Curry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Gui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20P.%22%2C%22lastName%22%3A%22Balachandran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Iacobuzio-Donahue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Chandwani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20S.%22%2C%22lastName%22%3A%22Leslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20D.%22%2C%22lastName%22%3A%22Leach%22%7D%5D%2C%22abstractNote%22%3A%22Unlike%20other%20malignancies%2C%20therapeutic%20options%20in%20pancreatic%20ductal%20adenocarcinoma%20%28PDAC%29%20are%20largely%20limited%20to%20cytotoxic%20chemotherapy%20without%20the%20benefit%20of%20molecular%20markers%20predicting%20response.%20Here%20we%20report%20tumor-cell-intrinsic%20chromatin%20accessibility%20patterns%20of%20treatment-na%5Cu00efve%20surgically%20resected%20PDAC%20tumors%20that%20were%20subsequently%20treated%20with%20%28Gem%29%5C%2FAbraxane%20adjuvant%20chemotherapy.%20By%20ATAC-seq%20analyses%20of%20EpCAM%2B%20PDAC%20malignant%20epithelial%20cells%20sorted%20from%2054%20freshly%20resected%20human%20tumors%2C%20we%20show%20here%20the%20discovery%20of%20a%20signature%20of%201092%20chromatin%20loci%20displaying%20differential%20accessibility%20between%20patients%20with%20disease%20free%20survival%20%28DFS%29%5Cu2009%3C%5Cu20091%20year%20and%20patients%20with%20DFS%5Cu2009%3E%5Cu20091%20year.%20Analyzing%20transcription%20factor%20%28TF%29%20binding%20motifs%20within%20these%20loci%2C%20we%20identify%20two%20TFs%20%28ZKSCAN1%20and%20HNF1b%29%20displaying%20differential%20nuclear%20localization%20between%20patients%20with%20short%20vs.%20long%20DFS.%20We%20further%20develop%20a%20chromatin%20accessibility%20microarray%20methodology%20termed%20%5Cu201cATAC-array%5Cu201d%2C%20an%20easy-to-use%20platform%20obviating%20the%20time%20and%20cost%20of%20next%20generation%20sequencing.%20Applying%20this%20methodology%20to%20the%20original%20ATAC-seq%20libraries%20as%20well%20as%20independent%20libraries%20generated%20from%20patient-derived%20organoids%2C%20we%20validate%20ATAC-array%20technology%20in%20both%20the%20original%20ATAC-seq%20cohort%20as%20well%20as%20in%20an%20independent%20validation%20cohort.%20We%20conclude%20that%20PDAC%20prognosis%20can%20be%20predicted%20by%20ATAC-array%2C%20which%20represents%20a%20low-cost%2C%20clinically%20feasible%20technology%20for%20assessing%20chromatin%20accessibility%20profiles.%22%2C%22date%22%3A%222021-05-24%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-021-23237-2%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41467-021-23237-2%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%223XSKJF5U%22%5D%2C%22dateModified%22%3A%222021-05-25T16%3A52%3A26Z%22%7D%7D%5D%7D
Dhara, S., Chhangawala, S., Chintalapudi, H., Askan, G., Aveson, V., Massa, A. L., Zhang, L., Torres, D., Makohon-Moore, A. P., Lecomte, N., Melchor, J. P., Bermeo, J., Cardenas, A., Sinha, S., Glassman, D., Nicolle, R., Moffitt, R., Yu, K. H., Leppanen, S., … Leach, S. D. (2021). Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility. Nature Communications, 12(1), 3044. https://doi.org/10.1038/s41467-021-23237-2 Cite
Full Article
Exit mobile version